Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer

Adenocarcinoma of the pancreas remains a highly lethal disease, with less than 5% survival at 5 years. Borderline resectable pancreatic cancer (BRPC) and locally advanced unresectable pancreatic cancer (LAPC) account for approximately 30% of newly diagnosed cases of PC. The objective of BRPC therapy...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncologist
Главные авторы: Shaib, Walid L., Ip, Andrew, Cardona, Kenneth, Alese, Olatunji B., Maithel, Shishir K., Kooby, David, Landry, Jerome, El-Rayes, Bassel F.
Формат: Artigo
Язык:Inglês
Опубликовано: AlphaMed Press 2016
Предметы:
Gastrointestinal Cancer
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4746088/
https://ncbi.nlm.nih.gov/pubmed/26834159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0316
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы